Neurocrine Biosciences (NBIX) Debt Ratio (2018 - 2024)

Neurocrine Biosciences (NBIX) has reported Debt Ratio for 6 consecutive years, with 0.04 the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Debt Ratio changed N/A year-over-year to 0.04; the trailing twelve-month figure through Mar 2024 stood at 0.04 (changed N/A YoY), and the FY2023 full-year result was 0.05, down 26.85% from the prior year.
• Debt Ratio fell to 0.04 in Q1 2024 per NBIX's latest filing, from 0.05 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.28 in Q3 2020 and bottomed at 0.04 in Q1 2024.
• Historically, Debt Ratio has averaged 0.12 across 4 years, with a median of 0.07 in 2022.
• The widest YoY moves for Debt Ratio: up 24.43% in 2023, down 26.85% in 2023.
• Over 4 years, Debt Ratio stood at 0.28 in 2020, then tumbled by 74.72% to 0.07 in 2022, then dropped by 26.85% to 0.05 in 2023, then tumbled by 32.4% to 0.04 in 2024.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.04, 0.05, and 0.06 for Q1 2024, Q4 2023, and Q3 2023 respectively.